biotech and therapies

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

alytas therapeutics GmbH

Biotech and Therapies

Alytas Therapeutics GmbH was incorporated in 2018 as a spin-off of the University of Jena and is based inJena, Germany. Its founders are experts in lipid-associated metabolic disorders and associated co-morbidities (like obesity).

Learn more

Lysatpharma GmbH

Biotech and Therapies

Lysatpharma focuses on regenerative medicine and new biomedical immunotherapies based on extracellular vesicles (exosomes).

Learn more

Firstgene Life Sciences GmbH

Biotech and Therapies

Firstgene Life Sciences GmbH focuses on innovative gene therapy approaches for the treatment of rare and common diseases.

Learn more

XRNA Biotech GmbH

Biotech and Therapies

XRNA Biotech is dedicated to researching various RNA molecules for targeted therapeutic applications in oncology.

Learn more

xprot GmbH

Biotech and Therapies

xprot is dedicated to developing new therapeutic approaches for lung cancer. The company has identified a protein that is downregulated in tumor samples from patients.

Learn more

xarma life sciences GmbH

Biotech and Therapies

xarma life sciences aims to develop top-tier functional and modulatory agents for the treatment of circulatory, immunological, and oncogenic diseases with unmet medical needs.

Learn more

Baliopharm AG

Biotech and Therapies

In April 2022, Baliopharm successfully completed Phase 1 clinical trials with the antibody Atrosimab, an antagonist of the TNFR1 receptor.

Learn more

QUADIRA BIOSCIENCES AG

Biotech and Therapies

Founded in 2021 in Solothurn, QUADIRA BIOSCIENCES AG is a joint venture between Anfass Life Technologies and Xlife Sciences. Leveraging technologies from abc biopply and Veraxa, it develops highly effective, better-tolerated ADCs for cancer therapy.

Learn more

Ix Therapeutics GmbH

Biotech and Therapies

The Ix Therapeuthics GmbH is a joint venture company founded by the Company and Indivumed GmbH in March 2021.

Learn more

x-kidney diagnostics GmbH

Biotech and Therapies

x-kidney diagnostics GmbH was incorporated in 2019 and is based in Erfurt, Germany. The company is dedicated to the development of new methods for the early identification of kidney diseases.

Learn more

x-nuclear diagnostics GmbH

Biotech and Therapies

x-nuclear diagnostic GmbH is a spin-off of University Hospital (Universitätsklinikum) Jena founded in 2019 and based in Erfurt, Germany.

Learn more